Regulation of Dihydropyrimidinase-like 3 Gene Expression by MicroRNAs in PC12 Cells with Induced Ischaemia and

Kisang Kwon1, Ji-Hye Song2, Hyewon Park3

  • 1Department of Clinical Laboratory Science, Wonkwang Health Science University, Iksan, South Korea.

Folia Biologica
|December 8, 2023
PubMed

Insights

Hypothermia aids ischemia recovery by altering specific microRNAs that regulate the Dpysl3 gene. These exosomal microRNAs offer potential therapeutic targets for ischemia treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Hypothermic treatment shows clinical benefits for ischemia, but underlying mechanisms remain unclear.
  • Understanding the molecular pathways involved in hypothermia's protective effects is crucial for therapeutic development.

Purpose of the Study:

  • To identify and characterize microRNAs associated with the dihydropyrimidinase-like 3 (Dpysl3) gene under conditions of ischemia and hypothermia.
  • To elucidate the regulatory roles of specific microRNAs in modulating Dpysl3 gene expression during ischemia-hypothermia.

Main Methods:

  • PC12 cells were subjected to chemical ischemia using CoCl2 and hypothermia at 32°C.
  • Exosomal microRNA analysis was performed to identify microRNAs related to the Dpysl3 gene.
  • Gene expression levels were analyzed to determine the regulatory effects of identified microRNAs on Dpysl3.

Main Results:

  • Four microRNAs (miR-106b-5p, miR-194-5p, miR-326-5p, and miR-497-5p) were found to be highly related to the Dpysl3 gene in ischemia-hypothermia.
  • miR-497-5p demonstrated an up-regulatory effect on Dpysl3 gene expression.
  • miR-106b-5p, miR-194-5p, and miR-326-5p exhibited down-regulatory effects on Dpysl3 gene expression.

Conclusions:

  • The identified microRNAs (miR-106b-5p, miR-194-5p, miR-326-5p, miR-497-5p) are involved in regulating Dpysl3 gene expression under ischemia-hypothermia.
  • Exosomal microRNAs represent potential therapeutic targets for managing ischemia.
  • Further research into these microRNAs could lead to novel treatment strategies for ischemia.